hydroxyurea has been researched along with eflornithine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Snapka, RM; Wani, MA | 1 |
Levin, VA | 1 |
Brelje, TC; Parsons, JA; Sorenson, RL | 1 |
Ask, A; Frostesjö, L; Heby, O; Holm, I; Persson, L; Rehnholm, A | 1 |
Demers, L; Manni, A; Mauger, D; Trout, D; Verderame, MF; Washington, S | 1 |
El-Saber Batiha, G; Igarashi, I; Magdy Beshbishy, A; Nadwa, E; Rashwan, E; Stephen Adeyemi, O; Yokoyama, N | 1 |
1 review(s) available for hydroxyurea and eflornithine
Article | Year |
---|---|
Chemotherapy of primary brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Eflornithine; Ependymoma; Fluorouracil; Glioblastoma; Humans; Hydroxyurea; Lomustine; Medulloblastoma; Methotrexate; Mitoguazone; Mitolactol; Neoplasm Recurrence, Local; Ornithine; Prednisone; Risk; Thioguanine; Vincristine | 1985 |
6 other study(ies) available for hydroxyurea and eflornithine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Drug-induced loss of unstably amplified genes.
Topics: Camptothecin; Dose-Response Relationship, Drug; Drug Resistance; Eflornithine; Gene Amplification; Guanazole; Hydroxyurea; Methotrexate; Proflavine; Tetrahydrofolate Dehydrogenase | 1990 |
Regulation of islet beta-cell proliferation by prolactin in rat islets.
Topics: Alkynes; Analysis of Variance; Animals; Animals, Newborn; Cell Division; Cells, Cultured; Colchicine; Diamines; Eflornithine; Hydroxyurea; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Ornithine Decarboxylase Inhibitors; Paclitaxel; Prolactin; Rats; Rats, Sprague-Dawley; Time Factors | 1994 |
Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit.
Topics: Animals; Blotting, Northern; Blotting, Southern; Cricetinae; Cricetulus; DNA Probes; Drug Resistance; Eflornithine; Electron Spin Resonance Spectroscopy; Gene Amplification; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Macromolecular Substances; Ornithine Decarboxylase; Polyamines; Ribonucleotide Reductases; RNA, Messenger; S-Adenosylmethionine; Tumor Cells, Cultured | 1993 |
Effect of alpha-difluoromethyl-ornithine on the expression and function of the epidermal growth factor receptor in human breast epithelial cells in culture.
Topics: Antineoplastic Agents; Blotting, Northern; Blotting, Western; Breast Neoplasms; Cell Line; Dose-Response Relationship, Drug; Eflornithine; Enzyme Inhibitors; Epithelial Cells; ErbB Receptors; Humans; Hydroxyurea; Nocodazole; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Polyamines; Protein Serine-Threonine Kinases; Receptor, ErbB-2; Signal Transduction; Tumor Cells, Cultured | 2001 |
Safety and efficacy of hydroxyurea and eflornithine against most blood parasites Babesia and Theileria.
Topics: Animals; Antineoplastic Agents; Antiprotozoal Agents; Atovaquone; Babesia; Cell Survival; Clofazimine; Diminazene; Dogs; Eflornithine; Foreskin; Humans; Hydroxyurea; Male; Mice; NIH 3T3 Cells; Theileria | 2020 |